Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05147584 · ClinicalTrials.gov registry record · NA
Trans-abdominal Fetal Pulse Oximetry
A NA study, sponsored by Raydiant Oximetry.
- Terminated
- Registry status
- NA
- Development phase
- 31
- Enrollment target
NCT05147584: Clinical Trial NA study, sponsored by Raydiant Oximetry.
NCT05147584 is a NA study that was terminated before completion, run by Raydiant Oximetry. The registered enrollment target is 31 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05147584, a NA study, was terminated before completion, sponsored by Raydiant Oximetry.
- TERMINATED
- Registry status
- NA
- Development phase
- 31 participants
- Enrollment target
Study Summary
The Raydiant Oximetry Sensing System (Lumerah) is a non-invasive fetal pulse oximeter that measures fetal arterial oxygen saturation using safe, non-invasive, transabdominal near-infrared spectroscopy. Lumerah is intended as an adjunct to cardiotocography by detecting decreases in fetal oxygenation.
Primary Outcome
Assessment of the adequacy of fetal signals from both internal and external fetal oxygen sensors.
Interventions
- DEVICE Dual fetal oxygen sensors
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 31 participants |
| Start Date | 2022-07-20 |
| Est. Completion | 2023-11-29 |
| Phase | NA |
Why NCT05147584 stopped before completion
NCT05147584 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 31 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Dual fetal oxygen sensors is the first listed.
NCT05147584 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05147584 about?
NCT05147584 is a clinical study titled "Trans-abdominal Fetal Pulse Oximetry". The Raydiant Oximetry Sensing System (Lumerah) is a non-invasive fetal pulse oximeter that measures fetal arterial oxygen saturation using safe, non-invasive, transabdominal near-infrared spectroscopy. Lumerah is intended as an adjunct to cardiotocography by detecting decreases in fetal oxygenation.
What is the current status of trial NCT05147584?
This trial is currently terminated. It is a NA study. The enrollment target is 31 participants. The study started on 2022-07-20. Estimated completion is 2023-11-29.
What interventions are being tested in trial NCT05147584?
The interventions under investigation include: Dual fetal oxygen sensors (DEVICE).
Who is sponsoring clinical trial NCT05147584?
This trial is sponsored by Raydiant Oximetry, which has 7 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05147584's enrollment target sits among peer trials
31 1592nd of 2000 higher than 408 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02932618 · 31 participants · Phase 3
A Study of Recombinant Von Willebrand Factor (rVWF) With or Without ADVATE in Children With Severe Von Willebrand Disease (VWD)
- NCT03482297 · 31 participants · Phase 1
Automated Abdominal Binder for Orthostatic Hypotension
- NCT04016389 · 31 participants · NA
FIGO 2018 Stage IB2 Cervical Cancer Treated With Neoadjuvant Chemotherapy Followed by Fertility Sparing Surgery
- NCT04211675 · 31 participants · Phase 1
NK Cells Infusions With Irinotecan, Temozolomide, and Dinutuximab
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI